|Bid||0.9200 x N/A|
|Ask||0.9300 x N/A|
|Day's Range||0.9100 - 1.0000|
|52 Week Range||0.0600 - 1.0000|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
VANCOUVER , Feb. 19, 2020 /CNW/ - Trading resumes in: Company: Else Nutrition Holdings Inc. TSX-Venture Symbol: BABY (All Issues) Resumption (ET): 9:30 AM IIROC can make a decision to impose a temporary ...
VANCOUVER , Feb. 19, 2020 /CNW/ - Else Nutrition Holdings Inc. (the "Company" or "Else Nutrition" or "Else") (BABY.V) (BABYF), a developer of novel plant based infant nutrition is pleased to announce that it has entered into an investment agreement with NewH2 Limited, a subsidiary of Health and Happiness (H&H) International Holdings Limited, a Hong Kong Stock Exchange Company(1112.HK), pursuant to which NewH2 has agreed to an investment of C$5.75 million in the Company, as part of an aggregate private placement offering of up to C$8.0 million . Pursuant to the private placement the Company will issue up to 12,383,900 (the "Units") at a price of C$0.646 per Unit.
The Company is a food and nutrition company focused on research, development, manufacturing, marketing, sale and/or licensing of innovative plant-based food and nutrition products to the infant, toddler, children and adult markets. Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Else Nutrition concluded a comprehensive U.S. customer study, conducted by Wizer, a leading market research provider. The study assessed the perceptions, needs and behavior of parents/caregivers regarding their children's nutrition, and their response to Else Nutrition product concept.
VANCOUVER, BC / ACCESSWIRE / January 22, 2020 / ELSE NUTRITION HOLDINGS INC. (BABY.V)(OTCQB:BABYF) ("Else Nutrition", "Else" or the "Company"), a developer of plant-based alternatives to dairy-based baby nutrition, announces today that it has received a formal notice of allowance from the U.S. Patent & Trademark office for the extension of the Company's existing patents to cover the market of adults suffering from malnutrition. The extension addresses the use of the company's proprietary formula for adults who have specific malnutrition related conditions such as lean body mass and declining basal metabolic rates.
"Both of these are highly encouraging developments as we intend to expand our future product portfolio to address the global adult population," stated Ms. Hamutal Yitzhak, CEO & Co-Founder of Else Nutrition. "Our 100% plant-based, whole-meal balanced nutrition, has a wide range of functional and meaningful applications for huge consumer markets, well beyond babies and children, as plant-based demand continues to grow world-wide in all segments of the population," she added.
VANCOUVER, BC / ACCESSWIRE / December 19, 2019 / ELSE NUTRITION HOLDINGS INC. (TSXV: BABY)(OTCQB:BABYF) ("Else" or the "Company"), a developer of a real alternative to dairy-based infant nutrition, is pleased to announce the following updates to shareholders. Else Nutrition has engaged an independent, full-service agency, The Sawtooth Group of Red Bank, New Jersey, for branding strategy and creative asset development.
VANCOUVER, Dec. 19, 2019 /CNW/ - ELSE NUTRITION HOLDINGS INC. (TSXV:BABY.V - News), (OTCQB: BABYF) ("Else" or the "Company"), a developer of a real alternative to dairy-based infant nutrition, is pleased to announce the following updates to shareholders. Else Nutrition has engaged an independent, full-service agency, The Sawtooth Group of Red Bank, New Jersey, for branding strategy and creative asset development.
VANCOUVER, Dec. 16, 2019 /CNW/ - ELSE NUTRITION HOLDINGS INC. (TSX-V: BABY, OTCQB: BABYF) ("Else" or the "Company"), a developer of plant-based alternatives to dairy-based baby nutrition, announces that it has received a favorable regulatory assessment of its toddler formula ingredients from EAS Consulting Group, LLC, which conducted a preliminary review of the Else formula in view of the FDA (Food and Drug Administration) requirements. With vast, global expertise in regulatory approvals, and specialty in FDA requirements, EAS has unique experience and capability pertaining to the introduction of food, drinks and new infant formulas.
VANCOUVER, BC / ACCESSWIRE / December 10, 2019 / Else Nutrition Holdings Inc. (" Else Nutrition " or the " Company ") ( TSXV:BABY ) ( OTCQB:BABYF ) is pleased to announce that its common ...
Vancouver, British Columbia--(Newsfile Corp. - November 28, 2019) - CEO of Else Nutrition Holdings, Hamutal Yitzhak speaks about the company's plant-based baby and toddler formula. Cannot view this video? Visit:https://www.b-tv.com/else-nutrition-plant-based-baby-formula-ceo-clip-90sec/Else Nutrition Holdings is being featured on BNN Bloomberg on November 30 - December 1, 2019, throughout the day and evenings.Else Nutrition Holdings Inc. (TSXV: BABY) www.elsenutrition.comAbout CEO Clips:CEO Clips is the largest library of publicly traded company CEO videos in Canada ...
TEL-AVIV, Israel , June 26, 2019 /CNW/ -- A-Labs Advisory & Finance Ltd. (" A-Labs ") announce today the successful closing of the round of finance in collaboration with Canaccord Genuity Inc. ...